drugset / Trial / NCT03822520

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

NCT03822520 ↗

Phase 1 Completed 28 enrolled Samsung Medical Center
RandomizedCrossoverOpen-labelOther

Summary

This study is conducted to evaluate effect on QT/QTc Interval after multiple dose of celecoxib among healthy adult volunteers. It is randomized, open-label, negative and postive control, and crossover study. Volunteers will be mainly checked up through ECG to find out changes of QT/QTc interval during the study.

Timeline

Start
2017-06-30
Primary completion
2018-05-25
Completion
2018-05-25

Outcome

Met primary endpoint

paper The largest time-matched mean effects of celecoxib on the QTcI and QTcF were <5 ms PMID 31564512 ↗

paper the upper bounds of the 1-sided 95% CIs of those values did not exceed 10 ms. PMID 31564512 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 400 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.